Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;22(9):1279.
doi: 10.1016/S1473-3099(22)00430-3. Epub 2022 Jul 14.

Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection

Fangfang Sun  1 , Yanwei Lin  1 , Xiaodong Wang  1 , Yuan Gao  2 , Shuang Ye  3
Affiliations

Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection

Fangfang Sun et al. Lancet Infect Dis. 2022 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The study protocol was approved by the ethics committees of Renji Hospital (2022-014-A). The study is supported by the Shanghai Hospital Development Center (SHDC; SHDC2020CR1015B) and Shanghai Municipal Health Commission (202040291). De-identified participants' data will be available on reasonable request to the corresponding author. All the authors declare no competing interests. FS and YL contributed equally to this manuscript.

References

    1. Zhang X, Zhang W, Chen S. Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic. Lancet. 2022;399:2011–2012. - PMC - PubMed
    1. Hammond J, Leister-Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med. 2022;386:1397–1408. - PMC - PubMed
    1. Belsky JA, Tullius BP, Lamb MG, Sayegh R, Stanek JR, Auletta JJ. COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients. J Infect. 2021;82:329–338. - PMC - PubMed
    1. National Health Commission of the People's Republic of China Diagnosis and treatment plan for COVID-19 (trial version 9) Int J Epidemiol Infect Dis. 2022;49:73–80.
    1. Agarwal A, Rochwerg B, Lamontagne F, et al. A living WHO guideline on drugs for covid-19. BMJ. 2020;370 - PubMed

Publication types